Amber Implants VCFix® spinal system receives US FDA Breakthrough Designation

The Hague, Netherlands, 5 October 2021: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces its VCFix® spinal system, which aims to improve the treatment of vertebral fractures, has been granted the Breakthrough Device Designation by the US FDA.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH